SEHK:2367Personal Products
Is Collagen Filler Approval Shaping the Investment Case for Giant Biogene Holding (SEHK:2367)?
Giant Biogene Holding Co., Ltd recently announced that its subsidiary received approval from the China National Medical Products Administration for a new collagen-based dermal filler designed to address facial dynamic wrinkles.
This approval underscores the company’s ongoing investment in skin rejuvenation technologies and further expands its offerings in the health and beauty industry.
We'll explore how this regulatory milestone, especially the focus on leveraging existing brands and...